Drawing for ALLIANCERX WALGREENS PRIME

USPTO serial 87353224

ALLIANCERX WALGREENS PRIME

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
EVANKO, PATRICIA MALESARDI
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALLIANCERX WALGREENS PRIME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Selena M. Spritz

104 Wilmot RoadMS #144ADeerfield, IL 60015

Goods and services

ClassDescriptionStatusFirst use
035Retail drug store services; retail pharmacy services; retail pharmacy services featuring specialty pharmaceuticals; retail pharmacy services featuring specialty pharmaceuticals provided via the Internet; retail pharmacy services featuring retrospective drug utilization review programs; specialized retail pharmacy services for patients with particular medical conditions; mail order services via a global computer network featuring pharmacy products and retail pharmacy services and medical suppliesACTIVE—
041Educational services, namely, providing courses in the fields of health and wellness; providing medication administration and health and wellness education services through live, printed, telephonic, and online classes and instruction; Educational services, namely, providing lectures, seminars and individual training for patient self-care of chronic disease statesACTIVE—
044Healthcare and medical services, namely, infusion therapy services; injectable therapies, ambulatory care and nursing care services; rental of medical equipment; dispensing of specialty pharmaceuticals; healthcare services, namely, reporting of results relating to clinical programs, therapy management programs, and disease management programs; interactive medical monitoring and alert services for reminding clients of medical information, namely, medicinal dosages, allergic sensitivity and prescription refills clinical pharmacy services, namely, preparing and dispensing home infused medication; prescription refill reminder services; Web-based health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended education resources and treatment informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 15, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 15, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 8, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 8, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 8, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 8, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 8, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 8, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 11, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 30, 2021TMBNTTAB RELEASE CASE TO TRADEMARKS—
Nov 30, 2021OP.TOPPOSITION TERMINATED NO. 999999—
Sep 15, 2021OP.DOPPOSITION DISMISSED NO. 999999—
Aug 31, 2017OP.IOPPOSITION INSTITUTED NO. 999999—
Aug 31, 2017OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Aug 1, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 1, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 12, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 25, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 25, 2017XAECEXAMINER'S AMENDMENT ENTERED—
May 25, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 25, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
May 25, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
May 23, 2017DOCKASSIGNED TO EXAMINER—
Mar 15, 2017TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Mar 15, 2017PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 8, 2017MPMKNOTICE OF PSEUDO MARK E-MAILED—
Mar 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 3, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance